Corporate

EXPANDING THEIR GLOBAL CLINICAL SERVICES, QPS AND INTELLIM TO FORM iQ PHARMA SERVICES - A JOINT VENTURE CONTRACT RESEARCH ORGANIZATION IN JAPAN

(December 10, 2012; Osaka, Japan) – QPS Holdings, LLC announced today that it has concluded an agreement with intellim Corporation to form a joint venture Contract Research Organization (CRO), named iQ Pharma Services Corporation, in Japan.

As trusted drug development partners for biopharmaceutical companies, both QPS and intellim provide total drug development solutions to their clients, from basic R&D to the various stages of clinical trial conduct.

Under the terms of the agreement, iQ Pharma Services will be organized to offer Phase II through Phase IV clinical research services in Japan, South Korea, Taiwan and China. QPS and intellim will both own 50% of iQ Pharma Services, which they expect to launch in the fourth quarter of 2012.

Mr. Ben Chien, QPS’ CEO, summarized this venture by saying, "We are optimistic that iQ Pharma Services will become the CRO of choice for Phase II through Phase IV contract clinical research in the Pacific/Asia region. Indeed, this strategic alliance with intellim is the perfect addition to further our own evolution as a global CRO. We are already seeing increased regional demand and we believe this alliance with intellim will allow us to intensify our presence in the Pacific/Asia region."

Mr. Ukita, intellim's CEO, had the following to say about his company’s relationship with QPS: "QPS is a first class CRO and, we believe, the ideal partner with which to build iQ Pharma Services. intellim will cover Japan and South Korea, and QPS will cover Taiwan, China and more. This alliance validates the strength of intellim's service portfolio and reputation, and the power of our business model to enable us to partner with other companies to promote our services. Because Japan is the second largest country for pharmaceutical companies in terms of new drug development and sales, and is interested in expanding its business to Asia and the other regions, we decided to base iQ Pharma Services in Japan. We believe iQ Pharma Services will quickly become essential to the pharmaceutical industry."

back
top
20 years in pharma R&D navigation